نتائج البحث 301-310 من 2887 لعملية البحث عن anti-TNF drugs
... treatment of patients with chronic myelomonocytic leukemia that has come back (recurrent) or that does not respond to treatment (refractory). Onvansertib is a ...
Drugs used in chemotherapy, such as cisplatin ... therapy selection tool for systemic therapy ... The purpose of this study is to determine the preliminary anti- ...
... treatment of male and female patients with ... treatment regimens including 1 platinum-based chemotherapy regimen for NSCLC. ... anti-neutrophil cytoplasmic ...
Chemotherapy drugs, such as capecitabine and temozolomide, work in different ... anti-T-cell immunoglobulin and ITM domain (TIGIT) monoclonal antibody ...
The goal of this clinical research study is to learn how often breast cancer recurs (returns after treatment) in the breast in patients who have been treated ...
Circulating Tumor Nucleic Acids to Monitor Treatment Response in Metastatic Melanoma Patients. Scottsdale/Phoenix, Ariz. This project will investigate whether ...
... therapy. Ascorbic acid may make cancer cells more sensitive to chemotherapy. Drugs used in chemotherapy, work in different ways to stop the growth of cancer ...
Drugs used in chemotherapy, such as cisplatin ... The purpose of this study is to determine the preliminary anti-tumor activity and confirm the safety of VV1 in ...
... therapy as measured by objective response rate (ORR) at one month. Onvansertib for the Treatment of Recurrent or Refractory Chronic Myelomonocytic Leukemia.
... drugs for diagnosing and treating aggressive tumor types or neoplastic processes. Genomic analyses mean looking at the genome, or all the DNA in a cell (DNA ...
لا تُقدم Mayo Clinic الدعم للشركات أو المنتجات المُعلَّن عنها هنا. لكن تدعم العائدات الإعلانية رسالتنا غير الربحية.
تحقق من هذه الكتب الأكثر مبيعًا والعروض الخاصة على الكتب والنشرات الإخبارية من Mayo Clinic Press.
تساهم التبرّعات، وهي قابلة للخصم الضريبي، في دعم آخر التطورات في الأبحاث وطرق الرعاية لإحداث نقلة نوعية في الطب.